Originalkatalog | Verfügbarkeit prüfen

Immunosenescence (iSenescence) correlates with progression (PD) to PD-(L)1 inhibitors (IO) and not to platinum-chemotherapy (PCT) in advanced non-small cell lung cancer (aNSCLC) pa...

M.C. Garassino, Boris Duchemann, David Planchard, J.J. Medhi, Lydie Cassard, Laura Mezquita, M. Naigeon, L. Boselli, Roberto Ferrara, Jonathan Grivel, Aude Desnoyer, Nathalie Chaput, Sabina Sangaletti, Edouard Auclin, Lizza E.L. Hendriks, Benjamin Besse, Caroline Caramella, J. Remon-Masip
2019